Horizon Discovery

Horizon Discovery is a revenue-generating life science group supplying research tools to organizations engaged in translational genomics research and the development of personalized medicines. Horizon has a diverse and international customer base of over 1,200 organizations across more than 50 countries, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers. The Group supplies its products and services into multiple markets, estimated to total in excess of £29 billion by 2015.
Horizon’s core capabilities are built around its proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Horizon offers over 20,000 catalogue products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases. These ‘patients-in-a-test-tube’ are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness, and resistance, which may lead to the successful prediction of which patient sub-groups will respond to currently available and future drug treatments. In addition, Horizon provides custom cell line and in vivo model generation services for research and bioproduction applications, quantitative molecular reference standards, in vivo disease models, and contract research and custom screening services.

Company Growth (employees)
Waterbeach, GB
Size (employees)
234 (est)
Horizon Discovery was founded in 2005 and is headquartered in Waterbeach, GB

Key People at Horizon Discovery

Chris Claxton

Chris Claxton

VP, Marketing
Kam Dhaliwal

Kam Dhaliwal

VP, Sales
Dan Cowell

Dan Cowell

VP, Operations
Ian Gilham

Ian Gilham

Interim Chairman

Horizon Discovery Office Locations

Horizon Discovery has offices in Waterbeach, Cambridge, Wien, St. Louis and in 1 other location
Waterbeach, GB (HQ)
Cambridge Research Park Beach Dr
Wien, AT
3 Campus Vienna Biocenter

Horizon Discovery Data and Metrics

Horizon Discovery Financial Metrics

Horizon Discovery's revenue was reported to be £20.2 m in FY, 2015 which is a 69% increase from the previous period.

Revenue (FY, 2015)

20.2 m

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

10 m

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

(9.9 m)

Market capitalization (19-Jul-2017)

240 m

Closing share price (19-Jul-2017)


Cash (31-Dec-2015)

25.1 m
Horizon Discovery's current market capitalization is £240 m.
GBPFY, 2013FY, 2014FY, 2015


6.6 m11.9 m20.2 m

Revenue growth, %


Cost of goods sold

3.2 m5.4 m10.2 m

Gross profit

3.4 m6.6 m10 m

Gross profit Margin, %


Operating expense total

6.4 m12.7 m20.3 m

Pre tax profit

(3 m)(6.1 m)(10.5 m)

Net Income

(3 m)(5.9 m)(9.9 m)
GBPFY, 2013FY, 2014FY, 2015


4.2 m18.5 m25.1 m

Accounts Receivable

1.4 m3.9 m5.9 m

Current Assets

6.7 m25.8 m36.5 m


3.6 m7 m8 m


561.9 k32.9 m44.4 m

Total Assets

10.9 m65.7 m88.9 m

Accounts Payable

1.4 m4.1 m3.9 m

Current Liabilities

2.7 m5.9 m6.8 m

Total Liabilities

3 m7.2 m9 m

Retained Earnings

(3 m)(5.9 m)(9.9 m)

Total Equity

7.9 m58.6 m79.9 m

Financial Leverage

1.4 x1.1 x1.1 x
GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

(2.2 m)(6.5 m)(11 m)

Cash From Financing Activities

3.7 m37.6 m24.3 m

Income Taxes Paid

72.6 k150 k661 k
GBPY, 2015


111.4 k

Financial Leverage

1.1 x

Horizon Discovery Market Value History

Horizon Discovery Online and Social Media Presence

Horizon Discovery News and Updates

Horizon Discovery Company Life and Culture

You may also be interested in